Clinical Trials Logo
  1. Home
  2. Cancer
  3. NCT06237816
  4. Details
NCT06237816 Clinical Trial

CTNow: A Clinical Trials Education Program for Rural Cancer Patients and Oncology Providers

Cancer Clinical Trial

Official title:
CTNow: A Clinical Trials Education Program for Rural Cancer Patients and Oncology Providers

Clinical Trial Details — Status: Not yet recruiting

Administrative data
NCT number NCT06237816
Other study ID # Okado-2023-2
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date May 2024
Est. completion date December 2025

Study information
Verified date May 2024
Source University of Hawaii
Contact Izumi Okado, PhD
Phone (808) 564-5978
Email iokado@cc.hawaii.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The overall goal of the project is to pilot test CTNow, a multilevel intervention designed to facilitate access and referrals to cancer clinical trials in rural areas through patient and provider education and teleconference resources.

Recruitment information / eligibility
Status Not yet recruiting
Enrollment 35
Est. completion date December 2025
Est. primary completion date July 2025
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patients must have been diagnosed with any cancer. - Patients who have received treatment, are receiving cancer treatment at the time of enrollment, or estimated to start treatment within 90 days. - Patients must be = 18 years of age. Patients must be able to read, write, and speak English. Study materials and telephone calls are only available in English. Patients must be residents of Hawaii, Kauai, or Maui counties. Exclusion Criteria: - Patients must not have previously participated in a cancer clinical trial. Those who have participated in a cancer clinical trial are not eligible for the study.

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• Patient Education Intervention
Multimedia Educational Videos
• Provider Education Intervention
Provider workshops via zoom

Locations
Country Name City State
n/a

Sponsors (2)
Lead Sponsor Collaborator
University of Hawaii Agency for Healthcare Research and Quality (AHRQ)

Outcome
Type Measure Description Time frame Safety issue
Primary Change in patients' awareness and knowledge of clinical trials Participants will complete a 12-item awareness and knowledge of clinical trials questionnaire at baseline and post-intervention. Items are reported on a Likert-type scale , with higher scores indicating greater knowledge. A paired t-test will be used to evaluate whether there is a statistically significant difference in pre- and post-intervention scores on patients' knowledge of clinical trials. 18 months
See also
  Status Clinical Trial Phase
Recruiting NCT05346796 - Survivorship Plan HEalth REcord (SPHERE) Implementation Trial N/A
Recruiting NCT05094804 - A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents Phase 1/Phase 2
Completed NCT04867850 - Effect of Behavioral Nudges on Serious Illness Conversation Documentation N/A
Enrolling by invitation NCT04086251 - Remote Electronic Patient Monitoring in Oncology Patients N/A
Completed NCT01285037 - A Study of LY2801653 in Advanced Cancer Phase 1
Completed NCT00680992 - Study of Denosumab in Subjects With Giant Cell Tumor of Bone Phase 2
Completed NCT00062842 - Study of Irinotecan on a Weekly Schedule in Children Phase 1
Active, not recruiting NCT04548063 - Consent Forms in Cancer Research: Examining the Effect of Length on Readability N/A
Completed NCT04337203 - Shared Healthcare Actions and Reflections Electronic Systems in Survivorship N/A
Recruiting NCT04349293 - Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways N/A
Terminated NCT02866851 - Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy N/A
Active, not recruiting NCT05304988 - Development and Validation of the EFT for Adolescents With Cancer
Completed NCT00340522 - Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
Recruiting NCT04843891 - Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis. Phase 1
Active, not recruiting NCT03844048 - An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial Phase 3
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A
Completed NCT03109041 - Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source Phase 1
Terminated NCT01441115 - ECI301 and Radiation for Advanced or Metastatic Cancer Phase 1
Recruiting NCT06206785 - Resting Energy Expenditure in Palliative Cancer Patients
Recruiting NCT05318196 - Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases